Literature DB >> 15254868

The human tumor microenvironment: invasive (needle) measurement of oxygen and interstitial fluid pressure.

Michael Milosevic1, Anthony Fyles, David Hedley, Richard Hill.   

Abstract

Invasive needle-based assessments of the extracellular environment in human tumors have yielded important prognostic information that has shaped the direction of future translational research and begun to influence clinical practice. This review focuses on electrode measurements of oxygenation in human tumors, particularly in relation to the practicalities of applying these techniques in the clinic and the relationship to patient outcome. Elevated tumor interstitial fluid pressure (IFP) has been shown to be an important independent prognostic factor in cervix cancer. The pathophysiology of elevated IFP is discussed, along with possible explanations for the strong influence on patient outcome and directions for future research.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15254868     DOI: 10.1016/j.semradonc.2004.04.006

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  43 in total

1.  Combining functional imaging and interstitial pressure measurements to evaluate two anti-angiogenic treatments.

Authors:  Ingrid Leguerney; Nathalie Lassau; Serge Koscielny; Mélanie Rodrigues; Christophe Massard; Valérie Rouffiac; Baya Benatsou; Jessie Thalmensi; Olivia Bawa; Paule Opolon; Pierre Peronneau; Alain Roche
Journal:  Invest New Drugs       Date:  2010-10-06       Impact factor: 3.850

2.  A highly sensitive biocompatible spin probe for imaging of oxygen concentration in tissues.

Authors:  Anna Bratasz; Aditi C Kulkarni; Periannan Kuppusamy
Journal:  Biophys J       Date:  2007-01-26       Impact factor: 4.033

3.  Direct measurement of hypoxia in a xenograft multiple myeloma model by optical-resolution photoacoustic microscopy.

Authors:  Toru Imai; Barbara Muz; Cheng-Hung Yeh; Junjie Yao; Ruiying Zhang; Abdel Kareem Azab; Lihong Wang
Journal:  Cancer Biol Ther       Date:  2017-01-03       Impact factor: 4.742

4.  Optimization of Weight Ratio for DSPE-PEG/TPGS Hybrid Micelles to Improve Drug Retention and Tumor Penetration.

Authors:  Ya Jin; Zimei Wu; Caibin Li; Weisai Zhou; John P Shaw; Bruce C Baguley; Jianping Liu; Wenli Zhang
Journal:  Pharm Res       Date:  2018-01-04       Impact factor: 4.200

5.  Evaluation of a hypoxia regulated gene panel in ovarian cancer.

Authors:  Amanda F Baker; Scott W Malm; Ritu Pandey; Cindy Laughren; Haiyan Cui; Denise Roe; Setsuko K Chambers
Journal:  Cancer Microenviron       Date:  2015-05-22

6.  Involvement of the mRNA binding protein CRD-BP in the regulation of metastatic melanoma cell proliferation and invasion by hypoxia.

Authors:  Evisabel A Craig; Jonathan D Weber; Vladimir S Spiegelman
Journal:  J Cell Sci       Date:  2012-10-04       Impact factor: 5.285

7.  Metabolic signature identifies novel targets for drug resistance in multiple myeloma.

Authors:  Patricia Maiso; Daisy Huynh; Michele Moschetta; Antonio Sacco; Yosra Aljawai; Yuji Mishima; John M Asara; Aldo M Roccaro; Alec C Kimmelman; Irene M Ghobrial
Journal:  Cancer Res       Date:  2015-03-13       Impact factor: 12.701

8.  Human cervical carcinoma xenograft models for studies of the physiological microenvironment of tumors.

Authors:  Christine Ellingsen; Ingrid Natvig; Jon-Vidar Gaustad; Kristine Gulliksrud; Tormod A M Egeland; Einar K Rofstad
Journal:  J Cancer Res Clin Oncol       Date:  2009-02-13       Impact factor: 4.553

9.  Dichloroacetate induces apoptosis and cell-cycle arrest in colorectal cancer cells.

Authors:  B M Madhok; S Yeluri; S L Perry; T A Hughes; D G Jayne
Journal:  Br J Cancer       Date:  2010-05-18       Impact factor: 7.640

10.  Radiocurability is associated with interstitial fluid pressure in human tumor xenografts.

Authors:  Einar K Rofstad; Jon-Vidar Gaustad; Kjetil G Brurberg; Berit Mathiesen; Kanthi Galappathi; Trude G Simonsen
Journal:  Neoplasia       Date:  2009-11       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.